Skip to Content Skip to Content

Health Sciences

Reset All Filters
2001 Results
Eczema Medication Unlikely to Increase Risk of Cancer in Children, Penn Team Finds

Eczema Medication Unlikely to Increase Risk of Cancer in Children, Penn Team Finds

The topical eczema medicine pimecrolimus appears unlikely to be associated with an increased risk of cancer in children, based on a group of children who were followed for 10 years, according to study published online this week in JAMA Dermatology.

Karen Kreeger

Penn Medicine Study Describes Development of Personalized Cellular Therapy for Brain Cancer

Penn Medicine Study Describes Development of Personalized Cellular Therapy for Brain Cancer

Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsy

Holly Auer

Common Biomarkers of Sleep Debt Found in Humans, Rats, Penn Study Finds

Common Biomarkers of Sleep Debt Found in Humans, Rats, Penn Study Finds

Stating that sleep is an essential biological process seems as obvious as saying that the sun rises every morning. Yet, researchers' understanding of the molecular mechanisms underlying the effects of sleep loss is still in its earliest stages.

Anna Duerr

Mosquitoes Ramp Up Immune Defenses After Sucking Blood, Penn Vet Researcher Finds

Mosquitoes Ramp Up Immune Defenses After Sucking Blood, Penn Vet Researcher Finds

If you were about to enter a crowded subway during flu season, packed with people sneezing and coughing, wouldn’t it be helpful if your immune system recognized the potentially risky situation and bolstered its defenses upon stepping into the train?

Katherine Unger Baillie

Penn Medicine's New Immunotherapy Study Will Pit PD-1 Inhibitor Against Advanced Lung Cancer

Penn Medicine's New Immunotherapy Study Will Pit PD-1 Inhibitor Against Advanced Lung Cancer

Penn Medicine researchers have begun a new immunotherapy trial with the “checkpoint inhibitor” known as pembrolizumab in patients with oligometastatic lung cancer—a state characterized by a few metastases in a confined area—who have completed conventional treatments and are considered free of active disease but remain at a high risk for recurrence.

Steve Graff

Sharp, Sustained Increases in Suicides Closely Shadowed Austerity Events in Greece, Penn Study Finds

Sharp, Sustained Increases in Suicides Closely Shadowed Austerity Events in Greece, Penn Study Finds

Sharp and significant increases in suicides followed select financial crisis events and austerity announcements in Greece, from the start of the country’s 2008 recession to steep spending cuts in 2012, Penn Medicine researchers report in a new study published online this week in the British  Medical Journal Open, along with colleagues from Greece and the United Kingdom.

Steve Graff